Results 101 to 110 of about 19,433 (209)

Hypophosphatemia after intravenous ferric carboxymaltose in lung transplant recipients

open access: yes
Background Intravenous ferric carboxymaltose ( FCM ) is frequently used to treat iron deficiency in lung transplant recipients ( LTRs
Silvia Ulrich   +8 more
core   +1 more source

Intravenous Iron–Induced Hypophosphatemia in Surgical Patients [PDF]

open access: yes
Intravenous (IV) iron has become a standard treatment for iron deficiency and anemia. Modern formulations of IV iron enable a large dose to be administered safely with a low complication rate comparable to other infusions.1 However, ferric carboxymaltose
Richards, Toby, Lim, J., Wijaya, L. K.
core   +1 more source

Incidence and Clinical Outcomes of Hypophosphatemia in Patients with Diabetic Ketoacidosis Admitted to a Tertiary Care Hospital

open access: yesPakistan Journal of Medicine and Dentistry
Background: Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus characterized by hyperglycemia, ketosis, and acidosis. Hypophosphatemia is a frequently overlooked yet clinically significant electrolyte disturbance during ...
Sadaf Abdullah   +5 more
doaj   +1 more source

Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia

open access: yesThe Egyptian Journal of Internal Medicine
Both denosumab-induced hypocalcemia and ferric carboxymaltose infusion-related hypophosphatemia have been extensively documented. There are significant risks associated with combining ferric carboxymaltose parenteral infusions and denosumab, including ...
Aysun Seker, Nurdan Senturk Durmus
doaj   +1 more source

Hypophosphatemia (Hypo-P) after liver resections

open access: yes, 1997
The article describes the biochemical and clinical patterns associated with hypophosphatemia after partial ...
Giovannini, Ivo   +6 more
core  

Home - About - Disclaimer - Privacy